Synmosa Biopharma Corporation (TPEX:4114)

Synmosa Biopharma Statistics

Total Valuation

TPEX:4114 has a market cap or net worth of TWD 15.75 billion. The enterprise value is 16.43 billion.

Market Cap	15.75B
Enterprise Value	16.43B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Aug 9, 2024

Share Statistics

TPEX:4114 has 455.25 million shares outstanding. The number of shares has increased by 2.15% in one year.

Current Share Class	455.25M
Shares Outstanding	455.25M
Shares Change (YoY)	+2.15%
Shares Change (QoQ)	+2.04%
Owned by Insiders (%)	10.43%
Owned by Institutions (%)	4.41%
Float	356.13M

Valuation Ratios

The trailing PE ratio is 20.70.

PE Ratio	20.70
Forward PE	n/a
PS Ratio	2.76
PB Ratio	1.69
P/TBV Ratio	2.05
P/FCF Ratio	25.20
P/OCF Ratio	18.21
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.05, with an EV/FCF ratio of 26.29.

EV / Earnings	23.14
EV / Sales	2.87
EV / EBITDA	15.05
EV / EBIT	21.67
EV / FCF	26.29

Financial Position

The company has a current ratio of 2.52, with a Debt / Equity ratio of 0.29.

Current Ratio	2.52
Quick Ratio	1.73
Debt / Equity	0.29
Debt / EBITDA	2.42
Debt / FCF	4.28
Interest Coverage	13.17

Financial Efficiency

Return on equity (ROE) is 5.55% and return on invested capital (ROIC) is 4.26%.

Return on Equity (ROE)	5.55%
Return on Assets (ROA)	3.75%
Return on Invested Capital (ROIC)	4.26%
Return on Capital Employed (ROCE)	6.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.45
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.68% in the last 52 weeks. The beta is -0.02, so TPEX:4114's price volatility has been lower than the market average.

Beta (5Y)	-0.02
52-Week Price Change	-6.68%
50-Day Moving Average	32.72
200-Day Moving Average	34.63
Relative Strength Index (RSI)	69.63
Average Volume (20 Days)	653,455

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4114 had revenue of TWD 5.72 billion and earned 710.08 million in profits. Earnings per share was 1.67.

Revenue	5.72B
Gross Profit	2.47B
Operating Income	771.49M
Pretax Income	667.62M
Net Income	710.08M
EBITDA	1.10B
EBIT	771.49M
Earnings Per Share (EPS)	1.67

Balance Sheet

The company has 3.13 billion in cash and 2.67 billion in debt, giving a net cash position of 460.49 million or 1.01 per share.

Cash & Cash Equivalents	3.13B
Total Debt	2.67B
Net Cash	460.49M
Net Cash Per Share	1.01
Equity (Book Value)	9.33B
Book Value Per Share	19.00
Working Capital	3.87B

Cash Flow

In the last 12 months, operating cash flow was 864.79 million and capital expenditures -239.76 million, giving a free cash flow of 625.03 million.

Operating Cash Flow	864.79M
Capital Expenditures	-239.76M
Free Cash Flow	625.03M
FCF Per Share	1.37

Margins

Gross margin is 43.25%, with operating and profit margins of 13.50% and 12.42%.

Gross Margin	43.25%
Operating Margin	13.50%
Pretax Margin	11.68%
Profit Margin	12.42%
EBITDA Margin	19.33%
EBIT Margin	13.50%
FCF Margin	10.94%

Dividends & Yields

This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 1.59%.

Dividend Per Share	0.55
Dividend Yield	1.59%
Dividend Growth (YoY)	18.41%
Years of Dividend Growth	4
Payout Ratio	32.21%
Buyback Yield	-2.15%
Shareholder Yield	-0.55%
Earnings Yield	4.51%
FCF Yield	3.97%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 9, 2024. It was a forward split with a ratio of 1.1.

Last Split Date	Aug 9, 2024
Split Type	Forward
Split Ratio	1.1

Scores

TPEX:4114 has an Altman Z-Score of 3.11.

Altman Z-Score	3.11
Piotroski F-Score	n/a